New: AutoArmy AI Readiness Assessment — a 30-minute path to your first AI use case. Book a free consultation

Life Sciences AI Consulting

Life Sciences AI Consulting for Pharma, Biotech, and Medical Device Leaders

AutoArmy’s life sciences AI consulting connects pharma, biotech, and medical device leaders with vetted experts, mapping a vendor-neutral path to faster discovery, cleaner trials, and compliant AI across the product lifecycle.

Services

Why Life Sciences Companies Cannot Afford to Delay AI Consulting

The science is hard and the rules are strict. McKinsey estimates gen AI could create $60 billion to $110 billion a year for pharma and medical products. These six gaps slow life sciences AI consulting most, each with the evidence behind it.

01

Falling Behind on Drug Discovery Timelines

Discovery takes years and billions. Rivals using AI screen targets in weeks, not months, compounding their lead. Slow, manual research cedes the best molecules to faster rivals. Speed is the whole game in discovery.

02

Clinical Trial Data Too Complex to Manage Manually

Trials drown teams in data. IBM finds only 29% of technology leaders say their data meets the standards AI needs. Messy trial data hides signals and slows decisions. Clean, connected data is the fix.

03

Regulatory Submissions Rejected Over AI Validation Gaps

Regulators now scrutinize AI closely. Peer-reviewed research counts 132 AI/ML submissions to the FDA in 2021, a tenfold jump. Weak validation gets a filing sent back. That delay can cost a quarter or more. Good validation prevents it.

04

No Internal Expertise for Medical Device AI Compliance

SaMD rules are unforgiving. Cisco finds only 31% of organizations say their talent is ready for AI. Few device teams hold deep AI compliance skills in-house. A matched partner brings them fast, without a long hire.

05

Missed Signals in Pharmacovigilance and Postmarket Data

Safety data piles up after launch. Gartner finds 63% of organizations lack the data practices AI needs. Buried signals delay action on adverse events. Patients deserve faster, safer answers. AI surfaces the safety signal sooner, before it becomes a crisis.

06

Generalist Tech Vendors Lack Life Sciences Domain Knowledge

The wrong vendor misreads the science. MIT finds AI bought from specialized vendors succeeds about 67% of the time, roughly double generic builds. Domain gaps cost time and credibility with regulators. The right specialist avoids that risk.

Services

Life Sciences AI Consulting Services

Every engagement stays advisory. We assess your goals, scope what fits a regulated setting, and guide the work safely. You own each decision, and FDA-aware governance is built in from the start.

01

AI Strategy and Roadmap for Life Sciences

Map where AI moves the needle across R&D, trials, and commercial. Advisory work scores use cases by value, feasibility, and regulatory risk. It then sequences a roadmap tied to ROI. The plan targets speed to market.

02

Clinical Trial AI and Data Automation

Tame the data that slows trials. Advisory scoping covers protocol design, cohort selection, and data automation across trial systems. Studies then enroll faster and amend less. The evidence comes out cleaner for submission.

03

Regulatory Compliance and FDA AI Validation

Build models regulators will accept. We align validation, documentation, and oversight to FDA expectations and the NIST AI RMF. Submissions and SaMD then hold up under review, not get returned.

04

AI in Pharmacovigilance and Drug Safety

Catch safety signals sooner. Advisory design applies machine learning to adverse event and real-world data, so pharmacovigilance teams spot trends earlier and protect patients across the postmarket lifecycle.

05

Genomic Analytics and Biotech AI Consulting

Turn genomic data into discovery. Scoping covers the pipelines and models that analyze genomic and multi-omic data. Biotech teams then find targets and biomarkers faster. The compute and governance are built to scale.

06

Life Sciences Manufacturing and Supply Chain AI

Protect quality and supply. Advisory work maps AI for manufacturing quality control and supply chain forecasting. Production then holds standards. Therapies reach patients on time. Shortages and recalls drop. Patients get their therapies on schedule. Trust holds.

Find Where AI Accelerates Your Pipeline
ADVISORY FRAMEWORK Fewer wrong turns · one signed route

Next step

Find Where AI Accelerates Your Pipeline

Get an independent read on your highest-value, FDA-aware AI opportunities, plus a roadmap your team can act on. No long commitment, just a clear next step.

Ready to lead with AI innovation? Book a free consultation

Use cases

Life Sciences AI Consulting Use Cases

These use cases deliver measurable value across the lifecycle. Each pairs a real workflow with the result it produces.

Life Sciences AI Consulting

AI-Powered Target Identification in Early Drug Discovery

Foundation models screen molecular targets in weeks, not months. Research teams then pursue the best candidates faster. Less effort goes to dead ends. The pipeline fills with stronger candidates. Bets get smarter, and budgets stretch further.

01
Life Sciences AI Consulting

Automated Protocol Design and Patient Cohort Selection

AI designs trial protocols and selects cohorts from real-world data. Studies enroll the right patients faster. Costly amendments and delays drop. Trials reach readouts sooner. Time saved is money saved, and patients wait less for new therapies.

02
Life Sciences AI Consulting

ML Models for FDA Submission Readiness and SaMD Compliance

Models check submission packages against regulatory expectations and flag validation gaps early. Regulatory teams then file with fewer rejections. Rework drops sharply. Reviews go more smoothly. Approvals come faster, and products reach market sooner.

03
Life Sciences AI Consulting

Real-World Evidence Analysis for Pharmacovigilance

AI scans real-world and postmarket data for safety signals. Adverse events surface earlier. Teams act fast, and patients stay protected after launch.

04
Life Sciences AI Consulting

Generative AI for Clinical Study Documentation

Gen AI drafts study reports and regulatory documents from source data. Medical writers move faster. Humans still review every claim before it goes out.

05
Life Sciences AI Consulting

AI-Driven Manufacturing Quality Control

AI inspects output and forecasts demand across the supply chain. Manufacturing holds quality and avoids the shortages that delay therapies and erode trust.

06

Why AutoArmy

Why Choose AutoArmy for Life Sciences AI Consulting

Our model is simple. Independent advice comes first, and a connection to the right delivery team follows. You get strategy and execution without the usual handoff gap.

Pre-Vetted Life Sciences AI Consulting Partners Only

Advisory comes first, then we connect you with vetted partners who know the science. You gain senior strategy plus a delivery team proven in regulated life sciences settings.

Matched to Your Exact Sub-Vertical

Partners are matched to pharma, biotech, or medical device, not a generic bucket. That fit means the team already knows your regulators, data, and product lifecycle. Less ramp-up, more progress.

Active FDA Regulatory and Compliance Experience

Partners bring real experience with FDA validation and SaMD rules. Your AI is built to pass review. A rejection that costs months is the risk we help you avoid.

Faster Than Traditional RFP Procurement

Skip the long RFP cycle. Because the network is vetted in advance, the right team starts in days, so your pipeline keeps moving instead of waiting on procurement.

HIPAA, GDPR, and SOC 2 Aligned Network

Every partner meets the privacy and security bar life sciences demands. Controls map to HIPAA, GDPR, and SOC 2, so patient and trial data stay protected.

Senior Domain Expertise From Day One

No generalist overhead or junior ramp-up. You work with people who know the science and the rules. The engagement moves fast, and the advice lands right.

Find the Right Life Sciences AI Partner Through AutoArmy
ADVISORY FRAMEWORK Fewer wrong turns · one signed route

Next step

Find the Right Life Sciences AI Partner Through AutoArmy

Tell us your pipeline and your goals. We will map the path and match you with a vetted, regulated-ready team. The first step is a short assessment.

Ready to lead with AI innovation? Book a free consultation

FAQ

Frequently Asked Questions About Life Sciences AI Consulting

Straight answers to the questions pharma and biotech leaders ask most.

Q. What is life sciences AI consulting and what does it cover?

It is advisory help that applies AI across the life sciences lifecycle: discovery, clinical trials, regulatory, safety, and manufacturing. Advisors assess your goals and compliance needs, prioritize use cases, and match you with a delivery team that knows the science. The aim is measurable value, like faster discovery and cleaner submissions, all under FDA-aware governance, not an experiment that stalls.

Q. How is AI being used in pharma and biotech today?

Widely, and growing fast. Teams use machine learning to identify drug targets, design trials, select patient cohorts, draft regulatory documents, and detect safety signals in real-world data. Generative AI now speeds medical writing and discovery. McKinsey estimates gen AI could add $60 billion to $110 billion a year to pharma and medical products, much of it from R&D and operations productivity.

Q. What should a CTO look for in a life sciences AI consulting partner?

Domain depth first: real experience with FDA validation, SaMD rules, and trial data, not generic AI skills. Look for proof in your sub-vertical, strong data privacy and security, and a track record of getting models through review. Favor advisors who stay vendor-neutral, so the recommendation fits your science and pipeline rather than a single platform.

Q. How does AutoArmy match us with the right life sciences AI consulting partner?

We begin with an advisory assessment of your goals, data, and compliance needs. From there we match you with vetted partners whose record fits your sub-vertical and regulators. Because we stay vendor-neutral, the recommendation follows your needs, not a quota. You keep one accountable advisor, gain a proven team, and approve the partner before any work begins.

Q. How long does it take to start a life sciences AI consulting engagement?

Faster than a traditional RFP. A focused assessment can begin within days, since the partner network is vetted in advance. An initial use case, like documentation AI or a discovery pilot, can show value in weeks. Advisors sequence the work so early wins are proven, and compliance is validated before scaling.

Q. What regulations do life sciences AI consulting partners need to understand?

At minimum, FDA expectations for AI used in drug submissions and Software as a Medical Device, plus HIPAA for protected health information and GDPR for global trials. Strong partners also map to the NIST AI RMF and SOC 2 for security. Advisors confirm a partner’s regulatory experience before any introduction, so your AI is built to pass review.

Make the right first conversation

Move forward — and make the right first conversation count.

Businesses see real AI returns by making fewer wrong decisions early. AutoArmy’s advisory process helps businesses make the right call before the budget is set.

Connect with our consultants 30 minutes · no cost · no sales deck
"Three weeks from intake to a working agent in your stack."
From the AutoArmy advisory brief · 2026